stella
beta
Triple Therapy for Intermediate-advanced HCC With BDTT (TALENP002) — Stella
Recruiting
Back to Hepatocellular Carcinoma trials
Trial locations
(6 sites)
China
First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian
Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian
Fujian Provincial Hospital, Fuzhou, Fujian
Zhongshan Hospital of Xiamen University, Xiamen, Fujian
First Affiliated Hospital of Xiamen University, Xiamen, Fujian
Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, Fujian
View full record on ClinicalTrials.gov